Electrophysiological Phenotyping of hiPSC-Derived Atrial Cardiomyocytes Using Automated Patch-Clamp: A Platform for

Verónica Jiménez-Sábado1,2,3, Hosna Babini1,2, Peter C Ruben2

  • 1Cellular and Regenerative Medicine Centre, BC Children's Hospital Research Institute, Vancouver, BC V5Z 4H4, Canada.

Cells
|December 24, 2025
PubMed

Insights

Human-induced pluripotent stem cell-derived atrial cardiomyocytes (hiPSC-aCMs) were characterized using automated patch-clamp. This method accurately records key atrial ion currents, aiding arrhythmia research.

Area of Science:

  • Cardiology
  • Electrophysiology
  • Stem Cell Biology

Background:

  • Human-induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) are vital for studying inherited cardiac disorders.
  • Atrial-specific hiPSC-CMs (hiPSC-aCMs) have unique electrophysiological properties requiring precise measurement techniques.

Purpose of the Study:

  • To optimize and validate automated patch-clamp methods for characterizing ion channel activity in hiPSC-aCMs.
  • To establish a reliable platform for investigating atrial ion channel function and its role in arrhythmias.

Main Methods:

  • Utilized the Nanion Patchliner automated patch-clamp system for hiPSC-aCM electrophysiology.
  • Developed optimized cell dissociation protocols and tailored ionic solutions for accurate current isolation.
  • Recorded major atrial ionic currents: INa, ICaL, Ito, IKur, ISK, and If.

Main Results:

  • Successfully characterized multiple atrial ion currents in hiPSC-aCMs with high reproducibility.
  • Observed current profiles consistent with native atrial cardiomyocytes.
  • Demonstrated the feasibility of automated electrophysiological profiling in hiPSC-aCMs.

Conclusions:

  • Automated patch-clamp is a feasible and efficient platform for characterizing ion channels in hiPSC-aCMs.
  • This approach facilitates the study of pathogenic variants and the development of therapies for atrial arrhythmias and channelopathies.